Identification of plasma miR-148a as a noninvasive biomarker for hepatocellular carcinoma

Bosch, 2005, Epidemiology of hepatocellular carcinoma, Clin Liver Dis, 9, 191, 10.1016/j.cld.2004.12.009 Van Hees, 2016, Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma, World J Gastroenterol, 22, 8271, 10.3748/wjg.v22.i37.8271 Bartel, 2018, Metazoan MicroRNAs, Cell, 173, 20, 10.1016/j.cell.2018.03.006 Bartel, 2009, MicroRNAs: target recognition and regulatory functions, Cell, 136, 215, 10.1016/j.cell.2009.01.002 Croce, 2009, Causes and consequences of microRNA dysregulation in cancer, Nat Rev Genet, 10, 704, 10.1038/nrg2634 Hu, 2018, Functional miRNAs in breast cancer drug resistance, Onco Targets Ther, 11, 1529, 10.2147/OTT.S152462 Calin, 2004, Human microRNA genes arefrequently located at fragile sites and genomic regions involved in cancers, Proc Natl Acad Sci USA, 101, 2999, 10.1073/pnas.0307323101 Friedrich, 2017, The role of the miR-148/-152 family in physiology and disease, Eur J Immunol, 47, 2026, 10.1002/eji.201747132 Fu, 2005, Identification of human fetal liver miRNAs by a novel method, FEBS Lett, 579, 3849, 10.1016/j.febslet.2005.05.064 Barad, 2004, MicroRNA expression detected byoligonucleotide microarrays: system establishment and expression profiling in human tissues, Genome Res., 14, 2486, 10.1101/gr.2845604 Landgraf, 2007, A mammalian microRNA expressionatlas based on small RNA library sequencing, Cell, 129, 1401, 10.1016/j.cell.2007.04.040 Manaster, 2012, MiRNA-mediated control of HLA-G expression and function, PLoS One, 7, e33395, 10.1371/journal.pone.0033395 Xu, 2013, Hepatitis B virus X protein repressesmiRNA-148a to enhance tumorigenesis, J Clin Invest, 123, 630 Abramovich, 2000, Functional cloning and characterization of a novel non-homeodomain protein that inhibits the binding of PBX1-HOX complexes to DNA, J Biol Chem, 275, 26172, 10.1074/jbc.M001323200 Lin, 2015, A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study, Lancet Oncol, 16, 804, 10.1016/S1470-2045(15)00048-0 Trevisani, 2001, Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status, J Hepatol, 34, 570, 10.1016/S0168-8278(00)00053-2 Gambarin-Gelwan, 2000, Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation, Am J Gastroenterol, 95, 1535, 10.1111/j.1572-0241.2000.02091.x Heo, 2014, microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 over expression, Oncotarget, 5, 2792, 10.18632/oncotarget.1920 Zhang, 2014, MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling, Oncogene, 33, 4069, 10.1038/onc.2013.369 Yan, 2014, Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma, Mol Carcinog, 53, 960, 10.1002/mc.22064 Gailhouste, 2013, miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells, Hepatology, 58, 1153, 10.1002/hep.26422 Long, 2014, microRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis, Int J Oncol, 44, 1915, 10.3892/ijo.2014.2373 Jung, 2016, Differentiation therapy for hepatocellular carcinoma: multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosis, Hepatology, 63, 864, 10.1002/hep.28367 Noetel, 2012, microRNA are central players in anti and profibrotic gene regulation during liver fibrosis, Front Physiol, 3, 49, 10.3389/fphys.2012.00049 Xu, 2016, TGF-β/SMAD pathway and its regulation in hepatic fibrosis, J Histochem Cytochem, 64, 157, 10.1369/0022155415627681 Jiang, 2014, The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells, PLoS One, 9, e96698, 10.1371/journal.pone.0096698 Jung, 2016, Differentiation therapy for hepatocellular carcinoma: multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosis, Hepatology, 63, 864, 10.1002/hep.28367 Zhang, 2013, Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis, Lancet Oncol, 14, 1295, 10.1016/S1470-2045(13)70491-1 Turchinovich, 2012, Extracellular miRNAs: the mystery of their origin and function, Trends Biochem Sci, 37, 460, 10.1016/j.tibs.2012.08.003 Wang, 2010, Correlation and quantitation of microRNA aberrant expression in tissues and serum from patients with breast tumor, Gynecol Oncol, 119, 586, 10.1016/j.ygyno.2010.07.021 Wong, 2012, Sequential alterations of microRNA expression in hepatocellular carcinoma development and venous metastasis, Hepatology, 55, 1453, 10.1002/hep.25512 Jiang, 2008, Association of microRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival, Clin Cancer Res, 14, 14419, 10.1158/1078-0432.CCR-07-0523 Huang, 2008, Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis, J Gastroenterol Hepatol, 23, 87, 10.1111/j.1440-1746.2007.05223.x Wang, 2008, Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target, J Biol Chem, 283, 13205, 10.1074/jbc.M707629200 Varnholt, 2008, MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma, Hepatology, 47, 1223, 10.1002/hep.22158 Stefaniuk, 2010, Present and future possibilities for early diagnosis of hepatocellular carcinoma, World J Gastroenterol, 16, 418, 10.3748/wjg.v16.i4.418 Sakamoto, 2014, MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis, Cancer Sci, 105, 236, 10.1111/cas.12330 Wang, 2015, NF-κB induces miR-148a to sustain TGF-beta/Smad signaling activation in glioblastoma, Mol Cancer, 14, 2, 10.1186/1476-4598-14-2 Li, 2016, The role of Mir-148a in cancer, J Cancer, 7, 1233, 10.7150/jca.14616 Wang, 2015, Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma, Tumor Biol, 37, 4945, 10.1007/s13277-015-4340-z